Stock Scorecard
Stock Summary for Teva- Pharmaceutical Industries Ltd (TEVA) - $37.34 as of 8/24/2026 12:45:03 PM EST
Total Score
8 out of 30
Safety Score
37 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TEVA
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TEVA
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TEVA
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TEVA
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TEVA (37 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for TEVA
Financial Details for TEVA
Company Overview |
|
|---|---|
| Ticker | TEVA |
| Company Name | Teva- Pharmaceutical Industries Ltd |
| Country | N/A |
| Description | Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 37.34 |
| Price 4 Years Ago | 9.12 |
| Last Day Price Updated | 8/24/2026 12:45:03 PM EST |
| Last Day Volume | 4,300,154 |
| Average Daily Volume | 5,509,528 |
| 52-Week High | 37.83 |
| 52-Week Low | 17.82 |
| Last Price to 52 Week Low | 109.54% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 51.19 |
| Sector PE | 65.79 |
| 5-Year Average PE | 11.26 |
| Free Cash Flow Ratio | 11.89 |
| Industry Free Cash Flow Ratio | 19.59 |
| Sector Free Cash Flow Ratio | 34.78 |
| Current Ratio Most Recent Quarter | 0.88 |
| Total Cash Per Share | 3.14 |
| Book Value Per Share Most Recent Quarter | 6.65 |
| Price to Book Ratio | 5.50 |
| Industry Price to Book Ratio | 34.68 |
| Sector Price to Book Ratio | 13.55 |
| Price to Sales Ratio Twelve Trailing Months | 2.52 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.04 |
| Sector Price to Sales Ratio Twelve Trailing Months | 22.58 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 1,165,296,000 |
| Market Capitalization | 43,512,152,640 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 11/27/2017 |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0850 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | -37.50% |
| 3-Year Dividend Growth Rate Percentage | -20.94% |
| 5-Year Dividend Growth Rate Percentage | -9.76% |
| All-Time Dividend Growth Rate Percentage | 20.29% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 72.20% |
| Annual Earnings Growth | 186.03% |
| Reported EPS 12 Trailing Months | 0.61 |
| Reported EPS Past Year | 1.17 |
| Reported EPS Prior Year | 2.89 |
| Net Income Twelve Trailing Months | 706,000,000 |
| Net Income Past Year | 1,410,000,000 |
| Net Income Prior Year | -1,639,000,000 |
| Quarterly Revenue Growth YOY | -0.80% |
| 5-Year Revenue Growth | 0.71% |
| Operating Margin Twelve Trailing Months | 4.03% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 3,655,000,000 |
| Total Cash Past Year | 3,555,945,000 |
| Total Cash Prior Year | 3,300,000,000 |
| Net Cash Position Most Recent Quarter | -8,437,000,000 |
| Net Cash Position Past Year | -11,430,055,000 |
| Long Term Debt Past Year | 14,986,000,000 |
| Long Term Debt Prior Year | 16,002,000,000 |
| Total Debt Most Recent Quarter | 12,092,000,000 |
| Equity to Debt Ratio Past Year | 0.35 |
| Equity to Debt Ratio Most Recent Quarter | 0.39 |
| Total Stockholder Equity Past Year | 7,909,877,000 |
| Total Stockholder Equity Prior Year | 5,373,000,000 |
| Total Stockholder Equity Most Recent Quarter | 7,757,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,348,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.16 |
| Free Cash Flow Past Year | 1,148,000,000 |
| Free Cash Flow Prior Year | 749,000,000 |
Options |
|
| Put/Call Ratio | 0.68 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.93 |
| MACD Signal | 0.51 |
| 20-Day Bollinger Lower Band | 29.68 |
| 20-Day Bollinger Middle Band | 33.46 |
| 20-Day Bollinger Upper Band | 37.23 |
| Beta | 0.88 |
| RSI | 68.30 |
| 50-Day SMA | 29.24 |
| 150-Day SMA | 20.02 |
| 200-Day SMA | 17.26 |
System |
|
| Modified | 8/22/2026 4:48:46 AM EST |